Opinion · Supreme Court of the United States

Stamps v. Collagen Corp

510 U.S. 824

Type
Opinion
Court
Supreme Court of the United States
Jurisdiction
Federal
Date
1993-10-04
Topic
general

How later courts describe this case

  • holding that existence of express preemption clause precludes reliance on implied preemption doctrine, without determining whether provision constituted a "reliable indicium of congressional intent"
  • holding that the analysis used in Ferebee did not survive the Cipollone decision
  • holding that the analysis used in Fer-ebee did not survive the Cipollone decision
  • finding that the express preemption provision in the MDA precludes any discussion regarding implied preemption
  • holding state law claims not preempted where FDA had established no specific requirements unique to the Class III medical device at issue
  • finding that the PMA process constitutes a “specific requirement” applicable to a particular device
  • “[W]e do not believe the [preemption] analysis [in Ferebee] can be said to have survived Cipollone-”
  • claims of failure to warn and defective design preempted where manufacturer of Class III device underwent PMA

Citator

UpLaw has not yet analyzed Stamps v. Collagen Corp. The absence of a flag is not a finding that it is good law.

Cited by
94 opinions

510 U.S. 824

Stamps
v.
Collagen Corp.

No. 92-1989.

Supreme Court of United States.

October 4, 1993.

1

Appeal from the C. A. 5th Cir.

2

Certiorari denied. Reported below: 984 F. 2d 1416.